• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • FDA lifts clinical hold from Mersana’s breast cancer trial fiercebiotech
    September 18, 2018
    The FDA has lifted the partial clinical hold it placed on a phase 1 trial of Mersana Therapeutics’ HER2-targeted antibody-drug conjugate (ADC). Regulatory officials put enrollment in the XMT-1522 breast cancer trial on hold in July after learning of the d
  • FDA hits Ziopharm CAR-T trial with clinical hold fiercebiotech
    June 25, 2018
    Until recently, Ziopharm’s top priority was to get inducible adenoviral vector Ad-RTS-hIL-12 into a pivotal brain cancer trial.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service